Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuroblastoma UK is a prominent British charity dedicated to funding research into neuroblastoma, a rare and often aggressive form of childhood cancer. The organization's primary mission is to improve survival rates and develop kinder treatments through the support of high-quality medical research projects at leading UK institutions. Since its founding, the charity has invested significantly in laboratory studies and early-phase clinical trials focused on genetic drivers and novel therapeutic targets. Beyond research, Neuroblastoma UK provides vital information to families and advocates for increased awareness and better care for affected children.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuroblastoma UK.